| Systematic (IUPAC) name | |
|---|---|
| 8-phenyl-1,3-dimethyl-7H-purine-2,6-dione | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 961-45-5 |
| ATC code | ? |
| PubChem | CID 1922 |
| ChemSpider | 1846 |
| ChEMBL | CHEMBL62350 |
| Chemical data | |
| Formula | C13H12N4O2 |
| Mol. mass | 256.259 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
8-Phenyltheophylline (8-Phenyl-1,3-dimethylxanthine, 8-PT) is a drug derived from the xanthine family which acts as a potent and selective antagonist for the adenosine receptors A1 and A2A, but unlike other xanthine derivatives has virtually no activity as a phosphodiesterase inhibitor.[1][2][3] It has stimulant effects in animals with similar potency to caffeine.[4] Coincidentally 8-phenyltheophylline has also been found to be a potent and selective inhibitor of the liver enzyme CYP1A2 which makes it likely to cause interactions with other drugs which are normally metabolised by CYP1A2.[5]
|
||||||||||||||||||||||
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)